Armata Pharmaceuticals, Inc. (ARMP) Stock News & Chart | StockAdder

(ARMP)

Armata Pharmaceuticals, Inc.

Stock chart and latest news for Armata Pharmaceuticals, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Armata Pharmaceuticals, Inc. News

PRO

Armata Pharmaceuticals (ARMP) Surges 103.2%: Is This an Indication of Further Gains?

Oct 23, 2025 Stock Titan

Armata pushes back earnings as FDA backs Phase 3 staph blood infection study

Mar 19, 2026 PR Newswire

Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02

Feb 23, 2026 The Globe and Mail

Armata Pharmaceuticals Sets Timeline for 2026 Annual Meeting

Apr 3, 2026 Seeking Alpha

Armata Pharmaceuticals: Intriguing Antibiotic Adjunct, But Too Many Potential Red Flags

Mar 12, 2026 Yahoo Finance

H.C. Wainwright Reaffirms Buy on Armata Pharmaceuticals, Inc. (ARMP) After FDA Nod

Mar 2, 2026 simplywall.st

A Look at Armata Pharmaceuticals’s Valuation After Positive Phase 2a Bacteriophage Trial Results (ARMP)

Oct 23, 2025 Stock Titan

Auditor flags going concern as Armata ends 2025 with $14.1M cash

Mar 25, 2026 PR Newswire

Armata Pharmaceuticals Announces End-of-Phase 2 Meeting with FDA and Plans to Advance AP-SA02 to a Phase 3 Superiority Study in Complicated Staphylococcus aureus Bacteremia

Jan 13, 2026 Seeking Alpha

Armata surges on trial data for antibacterial (ARMP:NYSE)

Oct 22, 2025 Yahoo Finance

Armata Pharmaceuticals, Inc. (ARMP) Reports Q3 Loss, Misses Revenue Estimates

Nov 12, 2025 PR Newswire

Armata Pharmaceuticals Announces Key Opinion Leader Webinar on S. aureus Bacteremia and AP-SA02 Hosted by Jones Research on November 25th at 10:00am EST